Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18879018 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL4250054 | 0.80 | ALDH1A1 (0.39) | NLRP3ALDH1A1 | |
| SCHEMBL11151049 | 0.80 | APEX1 (0.36) | ALDH1A1 | |
| SCHEMBL10827151 | 0.78 | NLRP3 (0.32) | NLRP3 | |
| SCHEMBL10669272 | 0.78 | ALDH1A1 (0.46) | NLRP3ALDH1A1 | |
| SCHEMBL4201443 | 0.78 | PLA2G2C (0.33) | NLRP3 | |
| SCHEMBL11316544 | 0.76 | NLRP3 (0.36) | NLRP3 | |
| SCHEMBL10669266 | 0.76 | NLRP3 (0.31) | NLRP3 | |
| SCHEMBL112027 | 0.76 | LMNA (0.46) | NLRP3 | |
| SCHEMBL16449384 | 0.76 | NLRP3 (0.31) | NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-4556480-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2025-05-21 | — | — | EP | disclosed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | disclosed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | disclosed |
| US-20240294541-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | FILECLO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2024-09-05 | — | — | US | disclosed |
| EP-4380939-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2024-06-12 | — | — | EP | disclosed |
| CN-118103377-A | Compounds constituting C20 modified salinomycin derivatives, process for obtaining the compounds, compositions containing the compounds and uses of said compounds | 菲莱克洛有限责任公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023012323-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | FILECLO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2023-02-09 | — | — | WO | disclosed |
| US-4283537-A | Thiazine-1,1-dioxide and isothiazole-1,1-dioxide derivatives and process for preparation | POLAROID CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| EP-0032036-A1 | Triarylmethane dyes, photographic recording materials, a process in which they are used, and methods for forming triarylmethane dyes | POLAROID CORPORATION (US) | 1981-07-15 | — | — | EP | disclosed |
| US-4277406-A | Novel triarylmethane compounds | POLAROID CORPORATION (US) | 1981-07-07 | — | — | US | disclosed |
| US-4259493-A | INDICATOR DYES OR PHOTOGRAPHIC LIGHT-SCREENING DYES | POLAROID CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-4210752-A | Synthesis of substituted sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-07-01 | — | — | US | disclosed |
| US-4186001-A | IRREVERSIBLE CLEAVAGE IN ALKALINE SOLUTION TO FORM COLORLESS COMPOUND | POLAROID CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-4122258-A | Process for producing desacetoxycephalosporin derivatives by heating a penicillin-1-oxide in presence of an organic sulfide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-10-24 | — | — | US | disclosed |
| US-3984401-A | Process for producing lactol-type cephalosporins | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | NLRP3 4702/4885ALDH1A1 327/4885 |
| US-20240294541-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | MRPS22, MRPS27, DHPS | NLRP3 4162/4885ALDH1A1 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.